EDISON, N.J., Dec. 4, 2012 /PRNewswire/ -- AAIPharma Services Corp. (“AAIPharma”), a leading provider of pharmaceutical product development services, announced today that it has appointed David Browne as the company’s director of analytical chemistry for its Edison, N.J. laboratory.
“We are excited to have David join the AAIPharma team,” said Vince Iuzzolino, director of site operations for AAIPharma’s Edison laboratory. “His leadership and expertise will be instrumental in growing and expanding the site’s analytical chemistry operation.”
Mr. Browne joins AAIPharma with more than 18 years of experience in analytical chemistry and laboratory management, most recently as director of analytical and quality at Gerhart. Prior to his position with Gerhart, Mr. Browne served as director of laboratory operations at Intertek, USA.
“AAIPharma’s commitment to technical excellence and quality mirrors my own philosophies, and it is refreshing to see an organization invest in its future development and growth through new technology, expansion and acquisitions,” Mr. Browne said. “I am looking forward to joining the team and contributing to the ongoing development of the organization.”
Mr. Browne earned his B.Sc. (Hons), DIS in Chemistry at Loughborough University of Technology in the United Kingdom.
About AAIPharma Services Corp.
AAIPharma Services Corp. is a leading provider of contract services that support all phases of drug development. The company’s wide array of capabilities includes analytical chemistry, formulation development, material testing services, microbiology, clinical and commercial contract manufacturing, pharmaceutical packaging and stability services. Serving more than 600 clients around the globe and headquartered in Wilmington, N.C., AAIPharma is a company of Water Street Healthcare Partners, a strategic private equity firm focused exclusively on health care.
For more information on the company, visit www.aaipharma.com.
SOURCE AAIPharma Services Corp.
